A Pharmaceutical & Life Science Industry Focus on COVID-19 Accounting Considerations

A Pharmaceutical & Life Science Industry Focus on COVID-19 Accounting Considerations

Publication date: 05 May 2020

COVID-19

Issues of the month
The coronavirus (COVID-19) pandemic has developed rapidly in 2020. Measures taken to contain the virus have affected economic activity, which in turn has implications for financial reporting. Click here for the details.
 
close
  • Add Selected section
  • OR
  • Add Full document
  • Print Selected section
  • OR
  • Print Full document
  • Copy link
  • Add to my favourites
close

Warning, this action will download the whole document into PDF format.

Cancel
close

Warning, this action will add the whole document to my documents.

Cancel
Back to top